Additionally, we found higher miR-195 expression levels could relate to poorer overall survival in prostate cancer patients according to TCGA (p = 0.013, Fig 6D) and is consistent with reduced COMT expression levels leading to lower overall survival rate in the same cohort (Fig 1D). The gene discussed is COMT; the disease is prostate cancer.